

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of fibroblast apoptotic process (GO:2000270) | 6.38447105 |
| 2 | cellular extravasation (GO:0045123) | 5.86348016 |
| 3 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 5.14382341 |
| 4 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 5.14382341 |
| 5 | protein-cofactor linkage (GO:0018065) | 5.01361301 |
| 6 | rRNA modification (GO:0000154) | 4.57445268 |
| 7 | rRNA methylation (GO:0031167) | 4.53597036 |
| 8 | regulation of triglyceride catabolic process (GO:0010896) | 4.39611180 |
| 9 | mast cell degranulation (GO:0043303) | 4.33387930 |
| 10 | mast cell activation involved in immune response (GO:0002279) | 4.33387930 |
| 11 | proteasome assembly (GO:0043248) | 4.23897940 |
| 12 | erythrocyte maturation (GO:0043249) | 4.04689886 |
| 13 | spliceosomal complex assembly (GO:0000245) | 3.98524413 |
| 14 | histone H2A acetylation (GO:0043968) | 3.98483808 |
| 15 | negative regulation of B cell apoptotic process (GO:0002903) | 3.94480993 |
| 16 | regulation of fibroblast apoptotic process (GO:2000269) | 3.92812643 |
| 17 | protein maturation by protein folding (GO:0022417) | 3.85081830 |
| 18 | establishment of integrated proviral latency (GO:0075713) | 3.83580555 |
| 19 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.76304756 |
| 20 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.73960813 |
| 21 | mannosylation (GO:0097502) | 3.73763973 |
| 22 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.73081289 |
| 23 | daunorubicin metabolic process (GO:0044597) | 3.71606402 |
| 24 | polyketide metabolic process (GO:0030638) | 3.71606402 |
| 25 | doxorubicin metabolic process (GO:0044598) | 3.71606402 |
| 26 | hepatocyte apoptotic process (GO:0097284) | 3.70303439 |
| 27 | cullin deneddylation (GO:0010388) | 3.69256523 |
| 28 | formation of translation preinitiation complex (GO:0001731) | 3.68110615 |
| 29 | COPI coating of Golgi vesicle (GO:0048205) | 3.63462916 |
| 30 | Golgi transport vesicle coating (GO:0048200) | 3.63462916 |
| 31 | CENP-A containing nucleosome assembly (GO:0034080) | 3.62690269 |
| 32 | establishment of viral latency (GO:0019043) | 3.57165563 |
| 33 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.51094115 |
| 34 | protein deneddylation (GO:0000338) | 3.50233606 |
| 35 | negative regulation of ligase activity (GO:0051352) | 3.49761631 |
| 36 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.49761631 |
| 37 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.49249815 |
| 38 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.47903511 |
| 39 | spliceosomal snRNP assembly (GO:0000387) | 3.42212106 |
| 40 | purine nucleobase biosynthetic process (GO:0009113) | 3.42140874 |
| 41 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.39991885 |
| 42 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.39991885 |
| 43 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.39611241 |
| 44 | ribonucleoprotein complex disassembly (GO:0032988) | 3.38947287 |
| 45 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.37314449 |
| 46 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.34876779 |
| 47 | nucleobase biosynthetic process (GO:0046112) | 3.34460979 |
| 48 | chromatin remodeling at centromere (GO:0031055) | 3.34284959 |
| 49 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.34035453 |
| 50 | ribosomal large subunit biogenesis (GO:0042273) | 3.30474502 |
| 51 | IMP biosynthetic process (GO:0006188) | 3.26720013 |
| 52 | ribosome biogenesis (GO:0042254) | 3.25595392 |
| 53 | mitochondrial DNA metabolic process (GO:0032042) | 3.24347685 |
| 54 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.21397236 |
| 55 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.21397236 |
| 56 | ribosomal small subunit assembly (GO:0000028) | 3.21111357 |
| 57 | L-methionine salvage (GO:0071267) | 3.19605509 |
| 58 | L-methionine biosynthetic process (GO:0071265) | 3.19605509 |
| 59 | amino acid salvage (GO:0043102) | 3.19605509 |
| 60 | histone arginine methylation (GO:0034969) | 3.19597416 |
| 61 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.18567373 |
| 62 | glycoside metabolic process (GO:0016137) | 3.17863808 |
| 63 | ribosome assembly (GO:0042255) | 3.17818082 |
| 64 | tRNA aminoacylation for protein translation (GO:0006418) | 3.17383727 |
| 65 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.16546288 |
| 66 | L-serine metabolic process (GO:0006563) | 3.14970754 |
| 67 | DNA strand elongation (GO:0022616) | 3.14934821 |
| 68 | rRNA processing (GO:0006364) | 3.13270752 |
| 69 | mitotic metaphase plate congression (GO:0007080) | 3.13054953 |
| 70 | tRNA aminoacylation (GO:0043039) | 3.13020827 |
| 71 | amino acid activation (GO:0043038) | 3.13020827 |
| 72 | DNA unwinding involved in DNA replication (GO:0006268) | 3.10736327 |
| 73 | telomere maintenance via recombination (GO:0000722) | 3.08384539 |
| 74 | lysosome localization (GO:0032418) | 3.07432134 |
| 75 | regulation of immunoglobulin secretion (GO:0051023) | 3.07193925 |
| 76 | NIK/NF-kappaB signaling (GO:0038061) | 3.05381437 |
| 77 | cerebellar Purkinje cell layer development (GO:0021680) | 3.03507843 |
| 78 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.02399929 |
| 79 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.01577869 |
| 80 | NADH dehydrogenase complex assembly (GO:0010257) | 3.01577869 |
| 81 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.01577869 |
| 82 | tricarboxylic acid cycle (GO:0006099) | 2.99710991 |
| 83 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.98686140 |
| 84 | pseudouridine synthesis (GO:0001522) | 2.97626051 |
| 85 | positive regulation of ligase activity (GO:0051351) | 2.96994705 |
| 86 | rRNA metabolic process (GO:0016072) | 2.94845947 |
| 87 | tRNA methylation (GO:0030488) | 2.94640830 |
| 88 | nuclear envelope reassembly (GO:0031468) | 2.94554754 |
| 89 | mitotic nuclear envelope reassembly (GO:0007084) | 2.94554754 |
| 90 | regulation of translation in response to stress (GO:0043555) | 2.94402619 |
| 91 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.94037721 |
| 92 | base-excision repair (GO:0006284) | 2.93585532 |
| 93 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.92897751 |
| 94 | mast cell activation (GO:0045576) | 2.90504676 |
| 95 | histone exchange (GO:0043486) | 2.89417855 |
| 96 | negative regulation of protein ubiquitination (GO:0031397) | 2.88441525 |
| 97 | maturation of SSU-rRNA (GO:0030490) | 2.87215861 |
| 98 | DNA replication initiation (GO:0006270) | 2.87016780 |
| 99 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.86585544 |
| 100 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.86585544 |
| 101 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.85969237 |
| 102 | oxidative phosphorylation (GO:0006119) | 2.85564601 |
| 103 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.83250519 |
| 104 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.83039258 |
| 105 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.82940378 |
| 106 | de novo protein folding (GO:0006458) | 2.80548471 |
| 107 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.80507750 |
| 108 | DNA replication-independent nucleosome organization (GO:0034724) | 2.80507750 |
| 109 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.79549910 |
| 110 | regulation of mitochondrial translation (GO:0070129) | 2.79381074 |
| 111 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176) | 2.78806392 |
| 112 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.78793776 |
| 113 | mitotic recombination (GO:0006312) | 2.78573182 |
| 114 | viral mRNA export from host cell nucleus (GO:0046784) | 2.78311955 |
| 115 | mitochondrial RNA metabolic process (GO:0000959) | 2.77907749 |
| 116 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.76197192 |
| 117 | protein targeting to mitochondrion (GO:0006626) | 2.75929708 |
| 118 | positive regulation of cell cycle arrest (GO:0071158) | 2.75355067 |
| 119 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.75000153 |
| 120 | regulation of translational fidelity (GO:0006450) | 2.74080808 |
| 121 | de novo posttranslational protein folding (GO:0051084) | 2.73830627 |
| 122 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.73785151 |
| 123 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.73686241 |
| 124 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.73686241 |
| 125 | mitotic nuclear envelope disassembly (GO:0007077) | 2.73635404 |
| 126 | organelle disassembly (GO:1903008) | 2.73573196 |
| 127 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.73491410 |
| 128 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.72365250 |
| 129 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.72184765 |
| 130 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.71865441 |
| 131 | peptidyl-arginine methylation (GO:0018216) | 2.71808729 |
| 132 | peptidyl-arginine N-methylation (GO:0035246) | 2.71808729 |
| 133 | GDP-mannose metabolic process (GO:0019673) | 2.71266713 |
| 134 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.70402993 |
| 135 | protein localization to kinetochore (GO:0034501) | 2.69905275 |
| 136 | regulation of B cell apoptotic process (GO:0002902) | 2.69828358 |
| 137 | telomere maintenance via telomere lengthening (GO:0010833) | 2.69740364 |
| 138 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.68994135 |
| 139 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.68994135 |
| 140 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.68994135 |
| 141 | peptidyl-histidine modification (GO:0018202) | 2.68882258 |
| 142 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.68617801 |
| 143 | cell cycle G1/S phase transition (GO:0044843) | 2.68617801 |
| 144 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.68366820 |
| 145 | regulation of ligase activity (GO:0051340) | 2.68220673 |
| 146 | 7-methylguanosine mRNA capping (GO:0006370) | 2.67639741 |
| 147 | transcription from mitochondrial promoter (GO:0006390) | 2.65560491 |
| 148 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.64873823 |
| 149 | folic acid metabolic process (GO:0046655) | 2.63987787 |
| 150 | mitotic sister chromatid segregation (GO:0000070) | 2.63428425 |
| 151 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.63293878 |
| 152 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.61788367 |
| 153 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.61350110 |
| 154 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.58766605 |
| 155 | proline biosynthetic process (GO:0006561) | 2.57598114 |
| 156 | tRNA metabolic process (GO:0006399) | 2.56891941 |
| 157 | RNA capping (GO:0036260) | 2.56706470 |
| 158 | 7-methylguanosine RNA capping (GO:0009452) | 2.56706470 |
| 159 | nucleoside salvage (GO:0043174) | 2.55231151 |
| 160 | regulation of cellular amine metabolic process (GO:0033238) | 2.54582709 |
| 161 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.54455096 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.58106106 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.20923924 |
| 3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.17766895 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.01964552 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.96275499 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.93737403 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.37750603 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.32456443 |
| 9 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.27030574 |
| 10 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.22100730 |
| 11 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.10335675 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.05175286 |
| 13 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.99327158 |
| 14 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.81682974 |
| 15 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.63002988 |
| 16 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.60283660 |
| 17 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.50610412 |
| 18 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.46252804 |
| 19 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.42937699 |
| 20 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.39253511 |
| 21 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.31159829 |
| 22 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.31059967 |
| 23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.29506535 |
| 24 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 2.26953536 |
| 25 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.22721943 |
| 26 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.20409976 |
| 27 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.19980273 |
| 28 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.19344380 |
| 29 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.17388307 |
| 30 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.15825537 |
| 31 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.13698986 |
| 32 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.09106924 |
| 33 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.04319812 |
| 34 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.91849082 |
| 35 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.89512614 |
| 36 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.86849866 |
| 37 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.84472548 |
| 38 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.83971266 |
| 39 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.78286825 |
| 40 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.78090247 |
| 41 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.76973746 |
| 42 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.74755237 |
| 43 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.72823100 |
| 44 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.70231486 |
| 45 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.68560468 |
| 46 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.66510286 |
| 47 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.65298828 |
| 48 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.65146667 |
| 49 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63006878 |
| 50 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.58085456 |
| 51 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.54553849 |
| 52 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.52315417 |
| 53 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.51880604 |
| 54 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48448328 |
| 55 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.46135875 |
| 56 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.43041512 |
| 57 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.42778873 |
| 58 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.27698476 |
| 59 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.27374884 |
| 60 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.26673292 |
| 61 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.25344620 |
| 62 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.24608013 |
| 63 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.21611886 |
| 64 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.19963129 |
| 65 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.19382420 |
| 66 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.18246015 |
| 67 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.18209099 |
| 68 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.18194730 |
| 69 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.14784757 |
| 70 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.14561673 |
| 71 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14342303 |
| 72 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.14319512 |
| 73 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.13620968 |
| 74 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12784213 |
| 75 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.12710703 |
| 76 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.12083340 |
| 77 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.11523538 |
| 78 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.10500468 |
| 79 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10195198 |
| 80 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.09638784 |
| 81 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.08499905 |
| 82 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08476980 |
| 83 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.08087338 |
| 84 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.06648385 |
| 85 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.06272585 |
| 86 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.04824235 |
| 87 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.04606504 |
| 88 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.04497605 |
| 89 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.03935859 |
| 90 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.02801689 |
| 91 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.01800714 |
| 92 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.01716149 |
| 93 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.99984614 |
| 94 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.99562579 |
| 95 | MYC_22102868_ChIP-Seq_BL_Human | 0.98537490 |
| 96 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.98300555 |
| 97 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.98284981 |
| 98 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.97115873 |
| 99 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.96441221 |
| 100 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.96027057 |
| 101 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.95875897 |
| 102 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.95210704 |
| 103 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.95074999 |
| 104 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.93718604 |
| 105 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.92971606 |
| 106 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.91753692 |
| 107 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.91656544 |
| 108 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.90742438 |
| 109 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.90518781 |
| 110 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.88114519 |
| 111 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.87980721 |
| 112 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.87418857 |
| 113 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.86905558 |
| 114 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.86361988 |
| 115 | GATA1_22025678_ChIP-Seq_K562_Human | 0.86144114 |
| 116 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.85722522 |
| 117 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.83813369 |
| 118 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.83585488 |
| 119 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.81631833 |
| 120 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.79511637 |
| 121 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.79377692 |
| 122 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.77380947 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004084_abnormal_cardiac_muscle | 4.12030109 |
| 2 | MP0008058_abnormal_DNA_repair | 3.79852476 |
| 3 | MP0010094_abnormal_chromosome_stability | 3.48364570 |
| 4 | MP0001853_heart_inflammation | 3.22512276 |
| 5 | MP0003111_abnormal_nucleus_morphology | 3.20674290 |
| 6 | MP0002877_abnormal_melanocyte_morpholog | 3.13157571 |
| 7 | MP0004147_increased_porphyrin_level | 3.00458951 |
| 8 | MP0008007_abnormal_cellular_replicative | 2.97373223 |
| 9 | MP0008877_abnormal_DNA_methylation | 2.93518933 |
| 10 | MP0008260_abnormal_autophagy | 2.91980129 |
| 11 | MP0003693_abnormal_embryo_hatching | 2.85643667 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.75967418 |
| 13 | MP0004036_abnormal_muscle_relaxation | 2.71560422 |
| 14 | MP0002396_abnormal_hematopoietic_system | 2.62621262 |
| 15 | MP0002254_reproductive_system_inflammat | 2.43966255 |
| 16 | MP0003077_abnormal_cell_cycle | 2.38126442 |
| 17 | MP0006036_abnormal_mitochondrial_physio | 2.30225518 |
| 18 | MP0003183_abnormal_peptide_metabolism | 2.26526407 |
| 19 | MP0004957_abnormal_blastocyst_morpholog | 2.15250375 |
| 20 | MP0002638_abnormal_pupillary_reflex | 2.08685941 |
| 21 | MP0003879_abnormal_hair_cell | 2.08475051 |
| 22 | MP0003806_abnormal_nucleotide_metabolis | 2.07392017 |
| 23 | MP0009840_abnormal_foam_cell | 2.03044013 |
| 24 | MP0003123_paternal_imprinting | 1.98166497 |
| 25 | MP0001529_abnormal_vocalization | 1.88760148 |
| 26 | MP0000465_gastrointestinal_hemorrhage | 1.80037635 |
| 27 | MP0001730_embryonic_growth_arrest | 1.79696981 |
| 28 | MP0008932_abnormal_embryonic_tissue | 1.75190367 |
| 29 | MP0001188_hyperpigmentation | 1.75134521 |
| 30 | MP0006276_abnormal_autonomic_nervous | 1.72148020 |
| 31 | MP0003315_abnormal_perineum_morphology | 1.64864150 |
| 32 | MP0003300_gastrointestinal_ulcer | 1.63127136 |
| 33 | MP0003122_maternal_imprinting | 1.57723865 |
| 34 | MP0003656_abnormal_erythrocyte_physiolo | 1.57431826 |
| 35 | MP0003436_decreased_susceptibility_to | 1.56786464 |
| 36 | MP0000490_abnormal_crypts_of | 1.56253148 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.56083655 |
| 38 | MP0002148_abnormal_hypersensitivity_rea | 1.49991624 |
| 39 | MP0005670_abnormal_white_adipose | 1.48045615 |
| 40 | MP0006035_abnormal_mitochondrial_morpho | 1.43996860 |
| 41 | MP0000358_abnormal_cell_content/ | 1.42187893 |
| 42 | MP0000372_irregular_coat_pigmentation | 1.40939100 |
| 43 | MP0003943_abnormal_hepatobiliary_system | 1.40330579 |
| 44 | MP0003186_abnormal_redox_activity | 1.40309522 |
| 45 | MP0010030_abnormal_orbit_morphology | 1.39627293 |
| 46 | MP0005084_abnormal_gallbladder_morpholo | 1.35573352 |
| 47 | MP0000604_amyloidosis | 1.34094589 |
| 48 | MP0003880_abnormal_central_pattern | 1.31273006 |
| 49 | MP0004808_abnormal_hematopoietic_stem | 1.30041674 |
| 50 | MP0000749_muscle_degeneration | 1.28088898 |
| 51 | MP0001697_abnormal_embryo_size | 1.26489346 |
| 52 | MP0004233_abnormal_muscle_weight | 1.26037443 |
| 53 | MP0005075_abnormal_melanosome_morpholog | 1.24514128 |
| 54 | MP0000350_abnormal_cell_proliferation | 1.20515864 |
| 55 | MP0005365_abnormal_bile_salt | 1.20251054 |
| 56 | MP0001835_abnormal_antigen_presentation | 1.18332765 |
| 57 | MP0003221_abnormal_cardiomyocyte_apopto | 1.17107251 |
| 58 | MP0002736_abnormal_nociception_after | 1.15891971 |
| 59 | MP0009278_abnormal_bone_marrow | 1.15558658 |
| 60 | MP0005464_abnormal_platelet_physiology | 1.12722202 |
| 61 | MP0003718_maternal_effect | 1.12204110 |
| 62 | MP0002080_prenatal_lethality | 1.11370384 |
| 63 | MP0004859_abnormal_synaptic_plasticity | 1.10312280 |
| 64 | MP0002837_dystrophic_cardiac_calcinosis | 1.09592965 |
| 65 | MP0004133_heterotaxia | 1.06184360 |
| 66 | MP0005266_abnormal_metabolism | 1.06063783 |
| 67 | MP0002234_abnormal_pharynx_morphology | 1.05742355 |
| 68 | MP0009672_abnormal_birth_weight | 1.04513655 |
| 69 | MP0001764_abnormal_homeostasis | 1.01752732 |
| 70 | MP0001346_abnormal_lacrimal_gland | 1.01517966 |
| 71 | MP0005501_abnormal_skin_physiology | 1.00526177 |
| 72 | MP0001968_abnormal_touch/_nociception | 0.99156458 |
| 73 | MP0002269_muscular_atrophy | 0.98372731 |
| 74 | MP0000015_abnormal_ear_pigmentation | 0.97693657 |
| 75 | MP0005384_cellular_phenotype | 0.97491532 |
| 76 | MP0010329_abnormal_lipoprotein_level | 0.96372488 |
| 77 | MP0009333_abnormal_splenocyte_physiolog | 0.96305207 |
| 78 | MP0008004_abnormal_stomach_pH | 0.95546358 |
| 79 | MP0000747_muscle_weakness | 0.94935010 |
| 80 | MP0004130_abnormal_muscle_cell | 0.93959713 |
| 81 | MP0001485_abnormal_pinna_reflex | 0.93618761 |
| 82 | MP0003172_abnormal_lysosome_physiology | 0.92618468 |
| 83 | MP0008875_abnormal_xenobiotic_pharmacok | 0.91944063 |
| 84 | MP0004043_abnormal_pH_regulation | 0.91081988 |
| 85 | MP0002722_abnormal_immune_system | 0.89340840 |
| 86 | MP0002909_abnormal_adrenal_gland | 0.89330327 |
| 87 | MP0000609_abnormal_liver_physiology | 0.88139455 |
| 88 | MP0009785_altered_susceptibility_to | 0.87431627 |
| 89 | MP0000689_abnormal_spleen_morphology | 0.87087256 |
| 90 | MP0005451_abnormal_body_composition | 0.86544896 |
| 91 | MP0003786_premature_aging | 0.85832447 |
| 92 | MP0000313_abnormal_cell_death | 0.84845019 |
| 93 | MP0000613_abnormal_salivary_gland | 0.83925608 |
| 94 | MP0005385_cardiovascular_system_phenoty | 0.83555961 |
| 95 | MP0001544_abnormal_cardiovascular_syste | 0.83555961 |
| 96 | MP0001661_extended_life_span | 0.82581438 |
| 97 | MP0002405_respiratory_system_inflammati | 0.80862724 |
| 98 | MP0010352_gastrointestinal_tract_polyps | 0.80036913 |
| 99 | MP0005621_abnormal_cell_physiology | 0.79441089 |
| 100 | MP0004811_abnormal_neuron_physiology | 0.79250874 |
| 101 | MP0005380_embryogenesis_phenotype | 0.78330787 |
| 102 | MP0001672_abnormal_embryogenesis/_devel | 0.78330787 |
| 103 | MP0003121_genomic_imprinting | 0.77001792 |
| 104 | MP0002429_abnormal_blood_cell | 0.75830319 |
| 105 | MP0002210_abnormal_sex_determination | 0.75810455 |
| 106 | MP0005165_increased_susceptibility_to | 0.75539426 |
| 107 | MP0000759_abnormal_skeletal_muscle | 0.74818377 |
| 108 | MP0005408_hypopigmentation | 0.74744835 |
| 109 | MP0008873_increased_physiological_sensi | 0.74513013 |
| 110 | MP0009697_abnormal_copulation | 0.73713070 |
| 111 | MP0003635_abnormal_synaptic_transmissio | 0.73656844 |
| 112 | MP0000003_abnormal_adipose_tissue | 0.72104204 |
| 113 | MP0000598_abnormal_liver_morphology | 0.71797261 |
| 114 | MP0010155_abnormal_intestine_physiology | 0.70398717 |
| 115 | MP0002970_abnormal_white_adipose | 0.70056518 |
| 116 | MP0003646_muscle_fatigue | 0.69739459 |
| 117 | MP0000371_diluted_coat_color | 0.69368304 |
| 118 | MP0002796_impaired_skin_barrier | 0.69141430 |
| 119 | MP0002272_abnormal_nervous_system | 0.68973190 |
| 120 | MP0002398_abnormal_bone_marrow | 0.68823912 |
| 121 | MP0009780_abnormal_chondrocyte_physiolo | 0.68630460 |
| 122 | MP0003119_abnormal_digestive_system | 0.68579685 |
| 123 | MP0003984_embryonic_growth_retardation | 0.68327626 |
| 124 | MP0002653_abnormal_ependyma_morphology | 0.68227036 |
| 125 | MP0001119_abnormal_female_reproductive | 0.67568102 |
| 126 | MP0009764_decreased_sensitivity_to | 0.67179717 |
| 127 | MP0000703_abnormal_thymus_morphology | 0.66871501 |
| 128 | MP0001216_abnormal_epidermal_layer | 0.66561898 |
| 129 | MP0002085_abnormal_embryonic_tissue | 0.66068964 |
| 130 | MP0001243_abnormal_dermal_layer | 0.65844698 |
| 131 | MP0002972_abnormal_cardiac_muscle | 0.65574650 |
| 132 | MP0008469_abnormal_protein_level | 0.65520328 |
| 133 | MP0006072_abnormal_retinal_apoptosis | 0.65389238 |
| 134 | MP0008789_abnormal_olfactory_epithelium | 0.65166028 |
| 135 | MP0002088_abnormal_embryonic_growth/wei | 0.64897837 |
| 136 | MP0001270_distended_abdomen | 0.64503457 |
| 137 | MP0005551_abnormal_eye_electrophysiolog | 0.64330063 |
| 138 | MP0001324_abnormal_eye_pigmentation | 0.64181213 |
| 139 | MP0002063_abnormal_learning/memory/cond | 0.64044791 |
| 140 | MP0002106_abnormal_muscle_physiology | 0.63960074 |
| 141 | MP0002019_abnormal_tumor_incidence | 0.63838839 |
| 142 | MP0003448_altered_tumor_morphology | 0.63707338 |
| 143 | MP0005330_cardiomyopathy | 0.62813908 |
| 144 | MP0002064_seizures | 0.62523239 |
| 145 | MP0000653_abnormal_sex_gland | 0.62224582 |
| 146 | MP0003137_abnormal_impulse_conducting | 0.61474225 |
| 147 | MP0001145_abnormal_male_reproductive | 0.60998285 |
| 148 | MP0002139_abnormal_hepatobiliary_system | 0.59895281 |
| 149 | MP0004087_abnormal_muscle_fiber | 0.59520885 |
| 150 | MP0002184_abnormal_innervation | 0.58536327 |
| 151 | MP0001929_abnormal_gametogenesis | 0.57928945 |
| 152 | MP0002075_abnormal_coat/hair_pigmentati | 0.57520586 |
| 153 | MP0002873_normal_phenotype | 0.57333104 |
| 154 | MP0002161_abnormal_fertility/fecundity | 0.56962877 |
| 155 | MP0009763_increased_sensitivity_to | 0.56846186 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cerebellar dysplasia (HP:0007033) | 6.91158656 |
| 2 | Anterior segment dysgenesis (HP:0007700) | 5.77501543 |
| 3 | Ependymoma (HP:0002888) | 5.51593133 |
| 4 | Type II lissencephaly (HP:0007260) | 5.39366127 |
| 5 | Increased serum pyruvate (HP:0003542) | 4.81384426 |
| 6 | Abnormality of glycolysis (HP:0004366) | 4.81384426 |
| 7 | Agnosia (HP:0010524) | 4.63021802 |
| 8 | Bundle branch block (HP:0011710) | 4.25504679 |
| 9 | Type I transferrin isoform profile (HP:0003642) | 3.95077628 |
| 10 | Cerebral hypomyelination (HP:0006808) | 3.72937223 |
| 11 | Reduced antithrombin III activity (HP:0001976) | 3.68611298 |
| 12 | Abnormality of the astrocytes (HP:0100707) | 3.64996227 |
| 13 | Astrocytoma (HP:0009592) | 3.64996227 |
| 14 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.63697896 |
| 15 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.63697896 |
| 16 | Abnormal protein glycosylation (HP:0012346) | 3.63697896 |
| 17 | Abnormal glycosylation (HP:0012345) | 3.63697896 |
| 18 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 3.57491293 |
| 19 | Hypoplasia of the brainstem (HP:0002365) | 3.57491293 |
| 20 | Prostate neoplasm (HP:0100787) | 3.55858332 |
| 21 | Medulloblastoma (HP:0002885) | 3.55225853 |
| 22 | Abnormality of the anterior horn cell (HP:0006802) | 3.43224396 |
| 23 | Degeneration of anterior horn cells (HP:0002398) | 3.43224396 |
| 24 | Hepatocellular necrosis (HP:0001404) | 3.33175759 |
| 25 | Lissencephaly (HP:0001339) | 3.26618411 |
| 26 | Hyperalaninemia (HP:0003348) | 3.19924020 |
| 27 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.19924020 |
| 28 | Abnormality of alanine metabolism (HP:0010916) | 3.19924020 |
| 29 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.18739850 |
| 30 | Microvesicular hepatic steatosis (HP:0001414) | 3.18395130 |
| 31 | Hepatic necrosis (HP:0002605) | 3.11254837 |
| 32 | Rough bone trabeculation (HP:0100670) | 3.10956681 |
| 33 | Visual hallucinations (HP:0002367) | 3.05868328 |
| 34 | Vacuolated lymphocytes (HP:0001922) | 2.98460190 |
| 35 | Vertebral compression fractures (HP:0002953) | 2.98250563 |
| 36 | Neuroendocrine neoplasm (HP:0100634) | 2.97046020 |
| 37 | Abnormal gallbladder physiology (HP:0012438) | 2.93104577 |
| 38 | Cholecystitis (HP:0001082) | 2.93104577 |
| 39 | Buphthalmos (HP:0000557) | 2.91567116 |
| 40 | Glioma (HP:0009733) | 2.90989214 |
| 41 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.90787637 |
| 42 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.89852908 |
| 43 | Severe muscular hypotonia (HP:0006829) | 2.89687909 |
| 44 | CNS hypomyelination (HP:0003429) | 2.88153350 |
| 45 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.87929315 |
| 46 | Multiple enchondromatosis (HP:0005701) | 2.80369063 |
| 47 | Spinal rigidity (HP:0003306) | 2.79268417 |
| 48 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.68092854 |
| 49 | Abnormal trabecular bone morphology (HP:0100671) | 2.65988113 |
| 50 | Lipid accumulation in hepatocytes (HP:0006561) | 2.61646874 |
| 51 | Neoplasm of the rectum (HP:0100743) | 2.61541820 |
| 52 | Increased cerebral lipofuscin (HP:0011813) | 2.60915462 |
| 53 | Pancytopenia (HP:0001876) | 2.60149108 |
| 54 | Rhabdomyosarcoma (HP:0002859) | 2.58026745 |
| 55 | Increased hepatocellular lipid droplets (HP:0006565) | 2.57469127 |
| 56 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.57366449 |
| 57 | Focal motor seizures (HP:0011153) | 2.56554953 |
| 58 | Hypokinesia (HP:0002375) | 2.47874965 |
| 59 | Mitochondrial inheritance (HP:0001427) | 2.46287375 |
| 60 | Testicular atrophy (HP:0000029) | 2.46137276 |
| 61 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.44429649 |
| 62 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.44429649 |
| 63 | Emotional lability (HP:0000712) | 2.44239801 |
| 64 | Symptomatic seizures (HP:0011145) | 2.43064499 |
| 65 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.39882020 |
| 66 | Increased CSF lactate (HP:0002490) | 2.39738515 |
| 67 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.37802417 |
| 68 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.37802417 |
| 69 | Abnormality of glycolipid metabolism (HP:0010969) | 2.37802417 |
| 70 | Unsteady gait (HP:0002317) | 2.36755168 |
| 71 | Acute necrotizing encephalopathy (HP:0006965) | 2.36648067 |
| 72 | Prominent metopic ridge (HP:0005487) | 2.33869903 |
| 73 | CNS demyelination (HP:0007305) | 2.31968835 |
| 74 | Postnatal microcephaly (HP:0005484) | 2.30019164 |
| 75 | Congenital glaucoma (HP:0001087) | 2.29654431 |
| 76 | Hypoplasia of the pons (HP:0012110) | 2.29041982 |
| 77 | Inability to walk (HP:0002540) | 2.27253978 |
| 78 | Increased intramyocellular lipid droplets (HP:0012240) | 2.26286101 |
| 79 | Pheochromocytoma (HP:0002666) | 2.26235386 |
| 80 | Progressive inability to walk (HP:0002505) | 2.25978783 |
| 81 | Progressive muscle weakness (HP:0003323) | 2.25880467 |
| 82 | Birth length less than 3rd percentile (HP:0003561) | 2.24970665 |
| 83 | Spastic paraparesis (HP:0002313) | 2.24841047 |
| 84 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.23069739 |
| 85 | Delayed CNS myelination (HP:0002188) | 2.22899168 |
| 86 | Intellectual disability, profound (HP:0002187) | 2.22830326 |
| 87 | Increased serum lactate (HP:0002151) | 2.22494675 |
| 88 | Secondary amenorrhea (HP:0000869) | 2.21329154 |
| 89 | Absence seizures (HP:0002121) | 2.20513320 |
| 90 | 11 pairs of ribs (HP:0000878) | 2.20300668 |
| 91 | Increased muscle lipid content (HP:0009058) | 2.20106118 |
| 92 | Cerebellar hypoplasia (HP:0001321) | 2.19760293 |
| 93 | Abnormality of the anterior chamber (HP:0000593) | 2.17985560 |
| 94 | Hypoglycemic seizures (HP:0002173) | 2.17662554 |
| 95 | Poor eye contact (HP:0000817) | 2.15775110 |
| 96 | Amaurosis fugax (HP:0100576) | 2.15477322 |
| 97 | Microretrognathia (HP:0000308) | 2.12952298 |
| 98 | Entropion (HP:0000621) | 2.11618629 |
| 99 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.11285127 |
| 100 | Loss of speech (HP:0002371) | 2.09745689 |
| 101 | Neoplasm of striated muscle (HP:0009728) | 2.09603643 |
| 102 | Neuroblastic tumors (HP:0004376) | 2.08068958 |
| 103 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 2.08068958 |
| 104 | Neuroblastoma (HP:0003006) | 2.08068958 |
| 105 | Primitive neuroectodermal tumor (HP:0030065) | 2.08068958 |
| 106 | Abnormality of the prostate (HP:0008775) | 2.07006549 |
| 107 | Retinal dysplasia (HP:0007973) | 2.07000492 |
| 108 | Increased IgM level (HP:0003496) | 2.06876161 |
| 109 | Abnormality of methionine metabolism (HP:0010901) | 2.06746987 |
| 110 | Acute encephalopathy (HP:0006846) | 2.05072871 |
| 111 | Trismus (HP:0000211) | 2.03131422 |
| 112 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.01180934 |
| 113 | Oral leukoplakia (HP:0002745) | 2.00948261 |
| 114 | Muscular dystrophy (HP:0003560) | 1.99832316 |
| 115 | Neoplasm of the small intestine (HP:0100833) | 1.99541915 |
| 116 | Heart block (HP:0012722) | 1.97950728 |
| 117 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.97706434 |
| 118 | Sparse eyelashes (HP:0000653) | 1.97647187 |
| 119 | Abnormality of the preputium (HP:0100587) | 1.97378581 |
| 120 | Renal Fanconi syndrome (HP:0001994) | 1.97313037 |
| 121 | Opisthotonus (HP:0002179) | 1.96430319 |
| 122 | Absent epiphyses (HP:0010577) | 1.96407317 |
| 123 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.96407317 |
| 124 | Lactic acidosis (HP:0003128) | 1.96274973 |
| 125 | Fasciculations (HP:0002380) | 1.95901277 |
| 126 | Abnormality of the umbilical cord (HP:0010881) | 1.95293700 |
| 127 | Abnormality of the pons (HP:0007361) | 1.94986455 |
| 128 | Upper limb muscle weakness (HP:0003484) | 1.94550350 |
| 129 | Abnormality of the intrinsic pathway (HP:0010989) | 1.92484016 |
| 130 | Gastrointestinal stroma tumor (HP:0100723) | 1.90219452 |
| 131 | Squamous cell carcinoma (HP:0002860) | 1.90035210 |
| 132 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.89398083 |
| 133 | Generalized muscle weakness (HP:0003324) | 1.89324293 |
| 134 | Cortical dysplasia (HP:0002539) | 1.88814954 |
| 135 | Hepatosplenomegaly (HP:0001433) | 1.88732956 |
| 136 | Premature ovarian failure (HP:0008209) | 1.88154681 |
| 137 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.88026037 |
| 138 | Horseshoe kidney (HP:0000085) | 1.87862292 |
| 139 | Biliary tract neoplasm (HP:0100574) | 1.87772257 |
| 140 | Abnormality of the vitreous humor (HP:0004327) | 1.87055894 |
| 141 | Neoplasm of the adrenal gland (HP:0100631) | 1.86855972 |
| 142 | Respiratory difficulties (HP:0002880) | 1.85130101 |
| 143 | Death in infancy (HP:0001522) | 1.84492910 |
| 144 | Cerebral edema (HP:0002181) | 1.84474977 |
| 145 | Ragged-red muscle fibers (HP:0003200) | 1.83552711 |
| 146 | Abnormal atrioventricular conduction (HP:0005150) | 1.83495152 |
| 147 | Autoimmune hemolytic anemia (HP:0001890) | 1.82373404 |
| 148 | Nonimmune hydrops fetalis (HP:0001790) | 1.82367121 |
| 149 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.79620144 |
| 150 | Macroglossia (HP:0000158) | 1.79505292 |
| 151 | Chromsome breakage (HP:0040012) | 1.79381733 |
| 152 | Hypoplastic pelvis (HP:0008839) | 1.79204183 |
| 153 | Progressive macrocephaly (HP:0004481) | 1.79046954 |
| 154 | Broad distal phalanx of finger (HP:0009836) | 1.78724693 |
| 155 | Delusions (HP:0000746) | 1.78313186 |
| 156 | Combined immunodeficiency (HP:0005387) | 1.78211390 |
| 157 | Polygenic inheritance (HP:0010982) | 1.76606006 |
| 158 | Myopathic facies (HP:0002058) | 1.76569783 |
| 159 | Oligomenorrhea (HP:0000876) | 1.76438733 |
| 160 | Exercise intolerance (HP:0003546) | 1.76150299 |
| 161 | Growth hormone excess (HP:0000845) | 1.75719649 |
| 162 | Acute lymphatic leukemia (HP:0006721) | 1.74975353 |
| 163 | Tongue fasciculations (HP:0001308) | 1.74758511 |
| 164 | Shoulder girdle muscle weakness (HP:0003547) | 1.74727136 |
| 165 | Abnormality of the metopic suture (HP:0005556) | 1.74541601 |
| 166 | Reticulocytopenia (HP:0001896) | 1.74336732 |
| 167 | Limb hypertonia (HP:0002509) | 1.74143995 |
| 168 | Hypergonadotropic hypogonadism (HP:0000815) | 1.73529588 |
| 169 | Self-mutilation (HP:0000742) | 1.73361214 |
| 170 | Hypoglycemic coma (HP:0001325) | 1.71647952 |
| 171 | Angiofibromas (HP:0010615) | 1.71060746 |
| 172 | Adenoma sebaceum (HP:0009720) | 1.71060746 |
| 173 | Aplastic anemia (HP:0001915) | 1.68871468 |
| 174 | Dialeptic seizures (HP:0011146) | 1.68732479 |
| 175 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.68084889 |
| 176 | Neoplasm of the colon (HP:0100273) | 1.67758793 |
| 177 | Carpal bone hypoplasia (HP:0001498) | 1.65970033 |
| 178 | Abnormality of the pupil (HP:0000615) | 1.64303662 |
| 179 | Limb-girdle muscle atrophy (HP:0003797) | 1.64160452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PIK3CG | 8.45701826 |
| 2 | EIF2AK1 | 4.06792417 |
| 3 | VRK2 | 3.99230916 |
| 4 | STK16 | 3.32692626 |
| 5 | SIK3 | 3.05857904 |
| 6 | BUB1 | 3.02503063 |
| 7 | NEK1 | 2.76238377 |
| 8 | INSRR | 2.60847590 |
| 9 | FLT3 | 2.52877504 |
| 10 | CCNB1 | 2.47602058 |
| 11 | TRIM28 | 2.34077784 |
| 12 | MAP3K10 | 2.20533299 |
| 13 | BCKDK | 2.20348333 |
| 14 | KIT | 2.10120453 |
| 15 | SMG1 | 2.07844198 |
| 16 | IRAK3 | 2.01725162 |
| 17 | SRPK1 | 1.99726586 |
| 18 | PASK | 1.88278380 |
| 19 | PDK3 | 1.80121693 |
| 20 | PDK4 | 1.80121693 |
| 21 | MAP3K12 | 1.72835797 |
| 22 | TESK1 | 1.67773016 |
| 23 | ZAK | 1.60928995 |
| 24 | BRAF | 1.56868022 |
| 25 | PIK3CA | 1.52859795 |
| 26 | ARAF | 1.45793602 |
| 27 | TSSK6 | 1.44736135 |
| 28 | MAP3K11 | 1.41580001 |
| 29 | TGFBR1 | 1.40546309 |
| 30 | EIF2AK3 | 1.40117445 |
| 31 | TLK1 | 1.36740109 |
| 32 | NME1 | 1.34923340 |
| 33 | ICK | 1.33724739 |
| 34 | EPHA2 | 1.32030949 |
| 35 | PRPF4B | 1.32023470 |
| 36 | WEE1 | 1.30587821 |
| 37 | BCR | 1.17349633 |
| 38 | CDC7 | 1.11185072 |
| 39 | MAP3K9 | 1.09509412 |
| 40 | SCYL2 | 1.08974841 |
| 41 | VRK1 | 1.06548215 |
| 42 | ABL2 | 1.06417634 |
| 43 | MAP2K6 | 1.04885081 |
| 44 | MST4 | 1.02697739 |
| 45 | PBK | 1.02666885 |
| 46 | ACVR1B | 1.01709829 |
| 47 | KSR1 | 1.00955299 |
| 48 | LIMK1 | 0.99747614 |
| 49 | MAP2K3 | 0.97241103 |
| 50 | MINK1 | 0.95460192 |
| 51 | MAP3K14 | 0.92609576 |
| 52 | PLK1 | 0.91651716 |
| 53 | STK10 | 0.91456281 |
| 54 | CSNK1A1L | 0.90773369 |
| 55 | CDK18 | 0.88377397 |
| 56 | MAP4K2 | 0.86529319 |
| 57 | MAP3K3 | 0.83635239 |
| 58 | DAPK1 | 0.83326513 |
| 59 | ERN1 | 0.81447733 |
| 60 | MAP3K13 | 0.80560243 |
| 61 | MATK | 0.80444074 |
| 62 | KDR | 0.78512879 |
| 63 | TESK2 | 0.78278847 |
| 64 | CDK8 | 0.78026842 |
| 65 | CSF1R | 0.75788125 |
| 66 | CDK19 | 0.75186857 |
| 67 | CLK1 | 0.74775857 |
| 68 | PAK4 | 0.73289976 |
| 69 | CDK15 | 0.72294726 |
| 70 | CSNK1G1 | 0.70540943 |
| 71 | PDK2 | 0.69861053 |
| 72 | TBK1 | 0.69538695 |
| 73 | CDK11A | 0.69423245 |
| 74 | TAF1 | 0.69054846 |
| 75 | PLK4 | 0.65648001 |
| 76 | EIF2AK2 | 0.65588031 |
| 77 | PIM2 | 0.64263330 |
| 78 | MST1R | 0.62709639 |
| 79 | CDK14 | 0.62397306 |
| 80 | NTRK3 | 0.61397904 |
| 81 | CDK9 | 0.58826249 |
| 82 | MARK1 | 0.58387632 |
| 83 | CSNK1G2 | 0.56911260 |
| 84 | LMTK2 | 0.55804702 |
| 85 | AURKA | 0.55607479 |
| 86 | NUAK1 | 0.55445961 |
| 87 | ATM | 0.54147362 |
| 88 | PLK3 | 0.53443292 |
| 89 | FER | 0.52438240 |
| 90 | ATR | 0.51623091 |
| 91 | STK4 | 0.51531996 |
| 92 | BRSK1 | 0.51354727 |
| 93 | EPHB1 | 0.50553561 |
| 94 | NEK2 | 0.50297555 |
| 95 | TAOK2 | 0.48910143 |
| 96 | DAPK3 | 0.47333699 |
| 97 | MYLK | 0.45041461 |
| 98 | RPS6KC1 | 0.44962957 |
| 99 | RPS6KL1 | 0.44962957 |
| 100 | DYRK2 | 0.44797513 |
| 101 | JAK3 | 0.42893001 |
| 102 | TIE1 | 0.42376682 |
| 103 | CDK4 | 0.42232114 |
| 104 | AKT2 | 0.41126401 |
| 105 | RPS6KA2 | 0.40540363 |
| 106 | PRKCI | 0.40087079 |
| 107 | RPS6KA4 | 0.39998156 |
| 108 | RPS6KA6 | 0.39304566 |
| 109 | NME2 | 0.37790264 |
| 110 | UHMK1 | 0.37331679 |
| 111 | ERBB4 | 0.36559389 |
| 112 | BRSK2 | 0.36558716 |
| 113 | CHEK1 | 0.35543512 |
| 114 | DAPK2 | 0.34924722 |
| 115 | AKT3 | 0.33057451 |
| 116 | CSNK2A2 | 0.32902741 |
| 117 | PAK1 | 0.32686106 |
| 118 | ALK | 0.32177258 |
| 119 | TEC | 0.31129965 |
| 120 | CDK12 | 0.29783244 |
| 121 | MAP3K8 | 0.29751444 |
| 122 | MAPK11 | 0.29233861 |
| 123 | TGFBR2 | 0.28681232 |
| 124 | DYRK3 | 0.25989393 |
| 125 | MAPK4 | 0.25957726 |
| 126 | CSNK1E | 0.25518627 |
| 127 | TTK | 0.24447114 |
| 128 | CSNK2A1 | 0.22228255 |
| 129 | AURKB | 0.20228393 |
| 130 | PRKG2 | 0.20132128 |
| 131 | RPS6KB1 | 0.18345236 |
| 132 | CDK7 | 0.16548463 |
| 133 | PRKD3 | 0.16486933 |
| 134 | PAK3 | 0.15674817 |
| 135 | CSNK1G3 | 0.14344594 |
| 136 | CDK1 | 0.14315658 |
| 137 | CDK2 | 0.14023737 |
| 138 | PRKCG | 0.11009541 |
| 139 | MAP3K5 | 0.10246617 |
| 140 | CAMKK2 | 0.10019107 |
| 141 | CHEK2 | 0.08641093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.83853621 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 3.62098200 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.07023724 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 3.05024814 |
| 5 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 3.00152791 |
| 6 | Spliceosome_Homo sapiens_hsa03040 | 2.44945980 |
| 7 | Sulfur relay system_Homo sapiens_hsa04122 | 2.44261618 |
| 8 | RNA polymerase_Homo sapiens_hsa03020 | 2.42725760 |
| 9 | Base excision repair_Homo sapiens_hsa03410 | 2.31626930 |
| 10 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.30777196 |
| 11 | Ribosome_Homo sapiens_hsa03010 | 2.26404064 |
| 12 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.25947385 |
| 13 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.22973141 |
| 14 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.13968415 |
| 15 | Parkinsons disease_Homo sapiens_hsa05012 | 2.12547195 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.07280832 |
| 17 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.97422161 |
| 18 | RNA transport_Homo sapiens_hsa03013 | 1.94617365 |
| 19 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.83806946 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.77597764 |
| 21 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.76861204 |
| 22 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.72979133 |
| 23 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.71414863 |
| 24 | Carbon metabolism_Homo sapiens_hsa01200 | 1.67948082 |
| 25 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.67794633 |
| 26 | Homologous recombination_Homo sapiens_hsa03440 | 1.53580503 |
| 27 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.47165994 |
| 28 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.46339513 |
| 29 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.44454308 |
| 30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.38631416 |
| 31 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.35937543 |
| 32 | Purine metabolism_Homo sapiens_hsa00230 | 1.31176655 |
| 33 | Other glycan degradation_Homo sapiens_hsa00511 | 1.30394770 |
| 34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.27299771 |
| 35 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.24961352 |
| 36 | Huntingtons disease_Homo sapiens_hsa05016 | 1.24712660 |
| 37 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.22984105 |
| 38 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.22388074 |
| 39 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.18781179 |
| 40 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.15569401 |
| 41 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.13383171 |
| 42 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.08064533 |
| 43 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.06591210 |
| 44 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.04690806 |
| 45 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.01798078 |
| 46 | Cell cycle_Homo sapiens_hsa04110 | 0.99460782 |
| 47 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.97837264 |
| 48 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.97772273 |
| 49 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.96773258 |
| 50 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.95900864 |
| 51 | Alzheimers disease_Homo sapiens_hsa05010 | 0.95821992 |
| 52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.95619742 |
| 53 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.93584506 |
| 54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.92665964 |
| 55 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.91964040 |
| 56 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.89756446 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.89142115 |
| 58 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.88451849 |
| 59 | RNA degradation_Homo sapiens_hsa03018 | 0.82641576 |
| 60 | Basal transcription factors_Homo sapiens_hsa03022 | 0.80894525 |
| 61 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.80385328 |
| 62 | Lysosome_Homo sapiens_hsa04142 | 0.79700697 |
| 63 | Protein export_Homo sapiens_hsa03060 | 0.78952755 |
| 64 | Peroxisome_Homo sapiens_hsa04146 | 0.78872860 |
| 65 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.77783388 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.77330875 |
| 67 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.74589887 |
| 68 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.73120992 |
| 69 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.69399008 |
| 70 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.68517827 |
| 71 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.66754711 |
| 72 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.65626072 |
| 73 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.65239699 |
| 74 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63984374 |
| 75 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62816932 |
| 76 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.61688745 |
| 77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61113826 |
| 78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.60260020 |
| 79 | Colorectal cancer_Homo sapiens_hsa05210 | 0.60072627 |
| 80 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59537124 |
| 81 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.58578012 |
| 82 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.57175647 |
| 83 | Thyroid cancer_Homo sapiens_hsa05216 | 0.55107616 |
| 84 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55053313 |
| 85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.54741807 |
| 86 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.54737797 |
| 87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50918693 |
| 88 | Legionellosis_Homo sapiens_hsa05134 | 0.50776049 |
| 89 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.49817175 |
| 90 | Shigellosis_Homo sapiens_hsa05131 | 0.49365998 |
| 91 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.48686765 |
| 92 | Apoptosis_Homo sapiens_hsa04210 | 0.47582283 |
| 93 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.47213798 |
| 94 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.47133242 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.46733568 |
| 96 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.46465594 |
| 97 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.44361437 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44315938 |
| 99 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42902329 |
| 100 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.42673164 |
| 101 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.40649282 |
| 102 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.40610183 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.40268428 |
| 104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.38311478 |
| 105 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.38065516 |
| 106 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.37156345 |
| 107 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.36659214 |
| 108 | Measles_Homo sapiens_hsa05162 | 0.36077381 |
| 109 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.35101973 |
| 110 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.35026352 |
| 111 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.34821423 |
| 112 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.34770500 |
| 113 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.34160693 |
| 114 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.33289057 |
| 115 | HTLV-I infection_Homo sapiens_hsa05166 | 0.32456938 |
| 116 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.30457148 |
| 117 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.29548077 |
| 118 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.29202847 |
| 119 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.29014267 |
| 120 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.28107920 |
| 121 | Melanoma_Homo sapiens_hsa05218 | 0.27936026 |
| 122 | Alcoholism_Homo sapiens_hsa05034 | 0.27380352 |
| 123 | Glioma_Homo sapiens_hsa05214 | 0.22601421 |
| 124 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.22022256 |
| 125 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.20582555 |
| 126 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.20381025 |
| 127 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.20163588 |
| 128 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.19703139 |
| 129 | Bladder cancer_Homo sapiens_hsa05219 | 0.19035906 |
| 130 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.17323752 |

